- Home
- PAVM vs SEED Comparison
PAVM vs SEED Comparison
Compare PAVM & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- SEED
- Stock Information
- Founded
- PAVM 2014
- SEED 1997
- Country
- PAVM United States
- SEED China
- Employees
- PAVM N/A
- SEED N/A
- Industry
- PAVM Medical/Dental Instruments
- SEED Farming/Seeds/Milling
- Sector
- PAVM Health Care
- SEED Consumer Staples
- Exchange
- PAVM Nasdaq
- SEED Nasdaq
- Market Cap
- PAVM 8.0M
- SEED 6.9M
- IPO Year
- PAVM 2016
- SEED N/A
- Fundamental
- Price
- PAVM $0.46
- SEED $1.02
- Analyst Decision
- PAVM Strong Buy
- SEED
- Analyst Count
- PAVM 1
- SEED 0
- Target Price
- PAVM $19.00
- SEED N/A
- AVG Volume (30 Days)
- PAVM 250.8K
- SEED 77.7K
- Earning Date
- PAVM 08-14-2025
- SEED 06-26-2025
- Dividend Yield
- PAVM N/A
- SEED N/A
- EPS Growth
- PAVM N/A
- SEED N/A
- EPS
- PAVM 0.96
- SEED N/A
- Revenue
- PAVM $1,993,000.00
- SEED $12,910,081.00
- Revenue This Year
- PAVM N/A
- SEED N/A
- Revenue Next Year
- PAVM $455.63
- SEED N/A
- P/E Ratio
- PAVM $0.48
- SEED N/A
- Revenue Growth
- PAVM N/A
- SEED N/A
- 52 Week Low
- PAVM $0.30
- SEED $0.74
- 52 Week High
- PAVM $1.90
- SEED $3.59
- Technical
- Relative Strength Index (RSI)
- PAVM 35.35
- SEED 51.13
- Support Level
- PAVM $0.43
- SEED $0.96
- Resistance Level
- PAVM $0.53
- SEED $1.10
- Average True Range (ATR)
- PAVM 0.05
- SEED 0.10
- MACD
- PAVM -0.01
- SEED 0.00
- Stochastic Oscillator
- PAVM 52.70
- SEED 37.93
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.